ANGELA LOWER: Open Payments
NPI 1740405497 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 40 payments from 21 companies in 2025. Trend: 2023 $510 · 2024 $929 · 2025 $916
Food & beverage: $916
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 6 | $118 |
| ARGENX US, INC. | 3 | $81 |
| EMD Serono, Inc. | 3 | $80 |
| Amneal Pharmaceuticals LLC | 4 | $73 |
| Eisai Inc. | 3 | $69 |
| SK Life Science, Inc. | 2 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| ABBVIE INC. | 2 | $53 |
| Aucta Pharmaceuticals, Inc. | 2 | $45 |
| Biogen, Inc. | 1 | $30 |
Products named: VYVGART HYTRULO, CREXONT, Leqembi, KESIMPTA, Fintepla, Motpoly XR, BOTOX, TYSABRI.
Industry payments across MI — which companies pay providers there.
